Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development.

Costi, Maria Paola; Ferrari, Stefania; Cavazzuti, Antonio

Inhibition of pteridine reductase (PTR1) — an enzyme essential for parasitic trypanosomatid survival — might represent a therapeutic approach for African sleeping sickness. Cavazzuti and colleagues combined a rapid-screening strategy using a folate-based library with structure-based design to identify PTR1 inhibitors with biological activity. An additive profile was observed when PTR1 inhibitors were used in combination with known dihydrofolate reductase inhibitors, indicating the potential of targeting two enzymes for the development of previously undescribed antiparasitic drugs.

Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development / Costi, Maria Paola; Ferrari, Stefania; Cavazzuti, Antonio. - STAMPA. - (2008).

Data di pubblicazione:	2008
Titolo:	Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
Autore/i:	Costi, Maria Paola; Ferrari, Stefania; Cavazzuti, Antonio
Autore/i UNIMORE:	COSTI, Maria Paola FERRARI, Stefania CAVAZZUTI, Antonio
Handle:	http://hdl.handle.net/11380/640695
Tipologia	Altro

File in questo prodotto:

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11380/640695

Citazioni

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris